Want to join the conversation?
$BSX's all three segments reported increased revenue growth YoverY. Of the three segments, MedSurg reported the highest 3Q15 revenue growth of 17% or 8% growth in organic terms, Cardiovascular reported a 9% increase or 6% in organic terms and Rhythm Management reported the lowest revenue growth of 2% or 2% organic, all on a constant currency basis.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?